156 related articles for article (PubMed ID: 28881357)
1. A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.
O'Sullivan D; Dowling P; Joyce H; McAuley E; McCann A; Henry M; McGovern B; Barham P; Kelleher FC; Murphy J; Kennedy S; Swan N; Moriarty M; Clynes M; Larkin A
Br J Cancer; 2017 Oct; 117(9):1326-1335. PubMed ID: 28881357
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
Leca J; Martinez S; Lac S; Nigri J; Secq V; Rubis M; Bressy C; Sergé A; Lavaut MN; Dusetti N; Loncle C; Roques J; Pietrasz D; Bousquet C; Garcia S; Granjeaud S; Ouaissi M; Bachet JB; Brun C; Iovanna JL; Zimmermann P; Vasseur S; Tomasini R
J Clin Invest; 2016 Nov; 126(11):4140-4156. PubMed ID: 27701147
[TBL] [Abstract][Full Text] [Related]
3. 7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.
O'Sullivan D; Henry M; Joyce H; Walsh N; Mc Auley E; Dowling P; Swan N; Moriarty M; Barnham P; Clynes M; Larkin A
Tumour Biol; 2014 Jul; 35(7):6983-97. PubMed ID: 24744142
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.
Korolkova OY; Widatalla SE; Whalen DS; Nangami GN; Abimbola A; Williams SD; Beasley HK; Reisenbichler E; Washington MK; Ochieng J; Mayer IA; Lehmann BD; Sakwe AM
PLoS One; 2020; 15(4):e0231711. PubMed ID: 32298357
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value.
Lomnytska MI; Becker S; Bodin I; Olsson A; Hellman K; Hellström AC; Mints M; Hellman U; Auer G; Andersson S
Br J Cancer; 2011 Jan; 104(1):110-9. PubMed ID: 21119665
[TBL] [Abstract][Full Text] [Related]
7. Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells.
Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F
Oncotarget; 2015 May; 6(13):11098-113. PubMed ID: 25860938
[TBL] [Abstract][Full Text] [Related]
8. Annexin A6 inhibits Ras signalling in breast cancer cells.
Vilá de Muga S; Timpson P; Cubells L; Evans R; Hayes TE; Rentero C; Hegemann A; Reverter M; Leschner J; Pol A; Tebar F; Daly RJ; Enrich C; Grewal T
Oncogene; 2009 Jan; 28(3):363-77. PubMed ID: 18850003
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma.
Tessier-Cloutier B; Kalloger SE; Al-Kandari M; Milne K; Gao D; Nelson BH; Renouf DJ; Sheffield BS; Schaeffer DF
BMC Cancer; 2017 Sep; 17(1):618. PubMed ID: 28870260
[TBL] [Abstract][Full Text] [Related]
10. A newly developed anti-Mucin 13 monoclonal antibody targets pancreatic ductal adenocarcinoma cells.
Nishii Y; Yamaguchi M; Kimura Y; Hasegawa T; Aburatani H; Uchida H; Hirata K; Sakuma Y
Int J Oncol; 2015 Apr; 46(4):1781-7. PubMed ID: 25672256
[TBL] [Abstract][Full Text] [Related]
11. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
[TBL] [Abstract][Full Text] [Related]
12. [Preparation of anti-B7-H4 monoclonal antibody to investigate B7-H4 expression in pancreatic cancer].
Hong B; Qian Y; Yao HP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 42(5):511-6. PubMed ID: 24167131
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
14. Combining phenotypic and proteomic approaches to identify membrane targets in a 'triple negative' breast cancer cell type.
Rust S; Guillard S; Sachsenmeier K; Hay C; Davidson M; Karlsson A; Karlsson R; Brand E; Lowne D; Elvin J; Flynn M; Kurosawa G; Hollingsworth R; Jermutus L; Minter R
Mol Cancer; 2013 Feb; 12():11. PubMed ID: 23406016
[TBL] [Abstract][Full Text] [Related]
15. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
[TBL] [Abstract][Full Text] [Related]
16. Inducing a humoral immune response to pancreatic cancer antigen.
Seifert M; Seifert G; Wolff-Vorbeck G; Langenmair E; Hopt UT; Wittel UA
Cell Immunol; 2016 Dec; 310():150-155. PubMed ID: 27663207
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.
Sipos B; Hahn D; Carceller A; Piulats J; Hedderich J; Kalthoff H; Goodman SL; Kosmahl M; Klöppel G
Histopathology; 2004 Sep; 45(3):226-36. PubMed ID: 15330800
[TBL] [Abstract][Full Text] [Related]
18. Functional screen for secreted proteins by monoclonal antibody library and identification of Mac-2 Binding protein (Mac-2BP) as a potential therapeutic target and biomarker for lung cancer.
Sun L; Chen L; Sun L; Pan J; Yu L; Han L; Yang Z; Luo Y; Ran Y
Mol Cell Proteomics; 2013 Feb; 12(2):395-406. PubMed ID: 23184915
[TBL] [Abstract][Full Text] [Related]
19. Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer.
Wang K; Dong M; Sheng W; Liu Q; Yu D; Dong Q; Li Q; Wang J
Histopathology; 2015 Sep; 67(3):386-97. PubMed ID: 25641222
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.
Byers JT; Paniccia A; Kaplan J; Koenig M; Kahn N; Wilson L; Chen L; Schulick RD; Edil BH; Zhu Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1574-9. PubMed ID: 25519928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]